Innopharma Receives Series B Investment

The main research direction of Innopharma is in the field of targeted diagnosis and treatment of cardiovascular atherosclerosis. Recently received B round of investment.

This article is reproduced from: https://www.itjuzi.com/investevent/13188661
This site is for inclusion only, and the copyright belongs to the original author.

Leave a Comment